Recombinant human thrombopoietin improved platelet engraftment after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

BACKGROUND: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) for hematopoietic reconstitution after autologous stem cell transplant (ASCT) in patients with newly diagnosed multiple myeloma (NDMM). METHOD: Thirty‐five cases with NDMM had been enrolled into a prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jingli, Liu, Junru, Li, Xiaozhe, Zou, Waiyi, Huang, Beihui, Chen, Meilan, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559510/
https://www.ncbi.nlm.nih.gov/pubmed/34569193
http://dx.doi.org/10.1002/cam4.4294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559510/
https://www.ncbi.nlm.nih.gov/pubmed/34569193
http://dx.doi.org/10.1002/cam4.4294

Ejemplares similares